In our latest episode, KYBORA‘s CEO, Alan Vanderborght, sits down with Richard Davies, Deputy Chairman of the Board at Alvotech, for a conversation about Richard’s extensive industry experience, the current state of Biopharma, funding hurdles and the future of the industry.
Listen to the episode below:



20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.